FDA Clears New Menopause Drug

The non-hormonal treatment was found to significantly reduce hot flashes and night sweats associated with menopause.

Ap
AP

According to a recent USA Today article, the FDA has approved Veozah, a drug developed by Astellas Pharma, to treat menopause symptoms. Veozah is a once-a-day pill that has been found to significantly reduce hot flashes and night sweats associated with menopause by blocking a chemical called neurokinin B (NKB) in the brain, which regulates body temperature. This drug is intended to replace traditional hormonal therapies that aren’t suitable for all patients, especially those with certain health conditions.

Have You Heard About our Podcasts?
Through the Line podcasts explore innovations and information across the packaging and processing landscape. Join us for the latest insights, trends, and strategies shaping packaging and processing today.
Listen Today
Have You Heard About our Podcasts?
Sustainable Healthcare Packaging Solutions That Work
Industry leaders share proven strategies for reducing packaging emissions by up to 70% while meeting safety and regulatory requirements.
Read More
Sustainable Healthcare Packaging Solutions That Work